Seema P. Deshpande

Seema P. Deshpande

Auto-generated profile, based on publicly available information

Seema P. Deshpande

From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
MMMichael A. Mazzeffi
Michael A. Mazzeffi
PSPatrick Stafford
Patrick Stafford
KWKarin Wallace
Karin Wallace
WBWendy Bernstein
Wendy Bernstein
SDSeema Deshpande
Seema Deshpande
PRPeter Rock
Peter Rock

25 December 2017 in Seminars in Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
SDSeema P. Deshpande
Seema P. Deshpande
MMMichael A. Mazzeffi
Michael A. Mazzeffi
ESErik Strauss
Erik Strauss
AHAllison Hollis
Allison Hollis
KTKenichi A. Tanaka
Kenichi A. Tanaka
Prostacyclin (prostaglandin I2 [PGI2]) is an eicosanoid lipid mediator produced by the endothelial cells. It plays pivotal roles in vascular homeostasis by virtue of its potent vasodilatory and antithrombotic effects. Stable pharmacological analogues of PGI2 are used for treatment of pulmonary hypertension and right ventricular failure. PGI2 dose dependently inhibits platelet activation induced by adenosine-5′-diphosphate, arachidonic acid, collagen, and low-dose thrombin. This property has led to its use as an alternative to direct thrombin inhibitors in patients with type II heparin-induced thrombocytopenia (HIT) undergoing cardiac surgery. The aims of this review are the following: (1) to review the pharmacology of PGI2 and its derivatives, (2) to present the evidence for their use in pulmonary hypertension and right heart failure, and (3) to discuss their utility in the management of HIT in cardiac surgery.

4 December 2024 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
SDSeema P. Deshpande
Seema P. Deshpande
RHReney A. Henderson
Reney A. Henderson
AAAniruddh U. Ajith
Aniruddh U. Ajith
AZAnn B. Zimrin
Ann B. Zimrin
BWBrittney Williams
Brittney Williams
Cancer-related coagulation abnormalities are characterized by complex dysregulation of the hemostatic system, predisposing patients to increased risk of thrombotic and hemorrhagic complications and associated increased morbidity and mortality. Advances in anticancer therapies with improved outcomes have led to better survival and older age of patients living with or having survived cancer. There is also a significant increase in the number of patients diagnosed with cancer. All these factors will increase the number of patients presenting for surgical procedures, both cancer-related and noncancer related. It is important for the anesthesiologist to understand the magnitude of cancer-related coagulation derangement, its types, pathophysiology, and clinical presentation, to optimize the perioperative management of this high-risk rapidly growing patient population.

9 November 2019 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
CECarlos O Encarnacion
Carlos O Encarnacion
SDSeema P Deshpande
Seema P Deshpande
SMSamhati Mondal
Samhati Mondal
SCShamus R Carr
Shamus R Carr
Postpneumonectomy syndrome can have a significant clinical impact on a patient. It presents as progressive dyspnoea due to compression of the contralateral bronchus and/or pulmonary veins. Herein, we present a patient who over a 2-year period developed progressive dyspnoea on exertion and eventually also at rest, due to compression of her left mainstem bronchus and her left inferior pulmonary vein. Surgical correction with implantable adjustable saline implants was undertaken to ameliorate her symptoms. Concurrent use of intraoperative transoesophageal echocardiography permitted real-time adjustment of the implants. This allowed objective measurement and demonstration of normalization of pulmonary vein velocity, which resulted in complete symptom resolution.

5 July 2022 in Cureus
Verified
Journal Article
Open access
LELauren Everett
Lauren Everett
TDTomMario A Davis
TomMario A Davis
SDSeema P. Deshpande
Seema P. Deshpande
SMSamhati Mondal
Samhati Mondal
Pain continues to be a well-known complication of cardiac surgery in the postoperative period and intravenous opioid analgesia has traditionally been employed to manage cardiac surgical pain. However, both components have contributed to a multitude of undesirable adverse effects which can further exacerbate delays in recovery. Often overlooked in the analgesic plan, chest tube pain contributes significantly to the overall postoperative pain from cardiac surgery. Novel regional anesthetic blocks have shown great promise as analgesic adjuncts for cardiothoracic anesthesia but preliminary investigations focus primarily on management of sternotomy pain. Reduction of chest tube pain should be considered while implementing regional blocks to control surgical pain. This study presents a case where the rectus sheath block minimized chest tube pain after aortic valve replacement in conjunction with intercostal nerve blocks and a multimodal analgesic plan.

1 August 2013 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
SDSeema P. Deshpande
Seema P. Deshpande
MFMolly Fitzpatrick
Molly Fitzpatrick
AGAlina M. Grigore
Alina M. Grigore